Trial Profile
Exploratory Study to Evaluate the Effect of Uninterrupted Anticoagulants in Catheter Ablation Procedure for Non-valvular Atrial Fibrillation - Comparison between Rivaroxaban and Warfarin -
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Cerebral infarction; Thromboembolism
- Focus Therapeutic Use
- Acronyms ASCERTAIN Study
- 02 Jan 2017 Status changed from active, no longer recruiting to completed according to the results presented at the 89th Annual Scientific Sessions of the American Heart Association.
- 16 Nov 2016 Primary endpoint (The incidence of asymptomatic cerebral infarction caused by catheter ablation) has not been met,according to the results presented at the 89th Annual Scientific Sessions of the American Heart Association.
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association.